Avail Clinical Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: DeLand FL United States (1998)

Organization Overview

First Clinical Trial
2008
NCT01183910
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Accel Research Sites (Avail Clinical Research) | Avail Clinical Research, LLC | Avail Clnical Research, LLC | Study Protocol, Inc. | STUDY PROTOCOL, INC

Active Ingredients

Drugs in Phase 3 Trials (2)

furosemide (lasix) (1 trial)

meloxicam (mobic) (1 trial)

Drugs in Phase 2 Trials (5)

Dapansutrile (1 trial)

doxycycline (vibramycin) (1 trial)

fedovapagon (1 trial)

s-equol (1 trial)

trimebutine (1 trial)

Drugs in Phase 1 Trials (2)

sap-001 (1 trial)

tirofiban (aggrastat) (1 trial)

Drugs in Other Trials (1)

citrus flavonoid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Colonic Diseases (Phase 2)

Gout (Phase 1)

Heart Failure (Phase 3)

Hyperuricemia (Phase 1)

Nocturia (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 2)

Renal Insufficiency (Phase 1)

Visceral Pain (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 10